Download Handout:
Run Time: 57 minutes

Approximately 50 million Americans, 20 percent of the population, suffer from autoimmune diseases and more than 100 autoimmune disorders have been identified to date. The good news? Low-dose naltrexone (LDN) has been studied recently regarding its application for autoimmune disorders. Sebastian will provide insight into the science, physiology and mechanisms of action of LDN, as well as the many conditions it may be beneficial for.